Uppsala Reports Long Reads – The KIDs List

It’s not always easy to choose the best medicine for a child.
Some drugs are inappropriate for young patients, while others
require special consideration or monitoring. For years,
clinicians had only historical dogmas, word of mouth and their
own experience to guide their choices. But a valuable new
resource promises to change paediatric prescribing for the
better.

This episode is part of the Uppsala Reports Long Reads series –
the most topical stories from UMC’s pharmacovigilance magazine,
brought to you in audio format. Find the original article
here.

After the read, we speak to Rachel Meyers and David Hoff, who
co-authored the KIDs List, to learn more about their work and the
overall challenges of medicines safety in children.

Tune in to find out:


Why adverse drug reactions tend to occur more often in the
paediatric population

How the KIDs List can improve prescribing for children 

How to collect even better safety information on paediatric
drugs in the future



Want to know more?
The KIDs List was first published in The Journal of
Pediatric Pharmacology and Therapeutics, where you can find more
information on how the list was compiled and how it is meant to
be used.

In an earlier commentary for the Journal of Pharmaceutical
Sciences, Rachel Meyers reflects on the changes she’d like to see
in how paediatric drugs are developed.

In Europe, the conect4children (c4c) project aims to speed up and
facilitate high-quality clinical trials in children while
ensuring that the voices of young patients and their families are
heard.

Finally, don’t forget to ­subscribe to the monthly Uppsala
Reports newsletter for free regular updates from the world of
pharmacovigilance.





Join the conversation on social mediaFollow us on
Facebook, LinkedIn, X, or Bluesky and share your thoughts about
the show with the hashtag #DrugSafetyMatters.

Got a story to share?We’re always looking for new
content and interesting people to interview. If you have a great
idea for a show, get in touch!

About UMCRead more about Uppsala Monitoring Centre
and how we work to advance medicines safety.